The Latest Breaking News from FDA

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

Letters: In all the domestic abuse cases where the CPS took no further action, it had made the right decision, says chief inspector Andrew T Cayley, while Duncan Woodhead of the FDA union also rejects claims of ‘cherrypicking’

Gene therapy has helped doctors make major strides in treating inherited blindness, and it's now being explored for other conditions.

Nationwide shortages of two dozen chemotherapy drugs are leading to rationing and delays in treatment for cancer patients, local and national authorities say.

Advocates say removing the barrier of prescriptions is long overdue

On Press Coverage In The Mifepristone Case.

Sunscreens work in two ways: either by blocking harmful UV rays from reaching the skin, or by converting the rays into heat that can be released from the body.

It can be easy to get your hopes up about exciting new research or alternative approaches to cancer treatment. Here's an insider's guide for figuring out which ones are worth your time.

In the past few years, 10,000 to 20,000 apps have stampeded into the mental health space, offering to “disrupt” traditional therapy. With the frenzy around AI innovations like ChatGPT, the claim that chatbots can provide mental health care is on the horizon.

In today’s newsletter: Semaglutide has won endorsements from celebrities and expert drugs advisers and has gone viral on TikTok. But don’t expect a quick fix

Respiratory illness kills hundreds of babies per year